Barely Significant
← all excerpts

Efficacy and safety of Lignosus rhinocerus (Cooke) Ryvarden TM02<sup>®</sup> supplementation for immune-challenged patients with localised breast cancer in remission: a randomised controlled trial.

BMC Complement Med Ther · 2025 · PMC12125795 · PMID 40450240

2
hedged sentences
closest p
boldest claim

The sentences

a decreasing trendno p-value reported
However, there was a decreasing trend in the mean fatigue score in both groups, with the score being lower in the TM02 ® group.

also in 47,180 other papers

a positive trendno p-value reported
TM02 ® supplementation showed a positive trend towards improved physical functioning and reduced fatigue scores.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.